Long Term Impact of Induced Abortion
Launched by PEKING UNION MEDICAL COLLEGE HOSPITAL · Jan 25, 2025
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the long-term effects of surgical and medical abortion on women in China. The goal is to understand how these procedures might affect women's health, their ability to have children in the future, and any complications that could arise during pregnancy. By gathering this information, researchers aim to provide valuable insights that can help improve health policies and guidelines related to abortion and fertility for women of childbearing age.
To participate in the trial, women aged 20 to 40 who are voluntarily seeking a non-medical abortion within the first 10 weeks of pregnancy may be eligible. Participants will need to be willing to have regular follow-up appointments after the procedure and sign a consent form to take part. It’s important to note that women who have had certain types of miscarriages or have difficulties with reading or understanding the information will not be included in the study. Overall, this research aims to ensure the safety and health of women undergoing these procedures and help shape future practices in reproductive health.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women who voluntarily request non-medical abortion surgery, early pregnancy (≤ 10 weeks of gestation); Age range: 20-40 years old (inclusive); Willingness to have another child; No long-term intention to go abroad during the research period; Willing to accept regular postoperative follow-up and voluntarily sign an informed consent form.
- Exclusion Criteria:
- • Pathological miscarriage such as spontaneous abortion and missed abortion; Difficulty in reading, writing, or understanding; Other situations deemed unsuitable for inclusion by doctors.
About Peking Union Medical College Hospital
Peking Union Medical College Hospital (PUMCH) is a prestigious medical institution and a leading research facility located in Beijing, China. Affiliated with the Chinese Academy of Medical Sciences, PUMCH is renowned for its commitment to advancing healthcare through innovative clinical research and high-quality patient care. The hospital plays a pivotal role in the development and execution of clinical trials across various medical disciplines, focusing on improving treatment outcomes and enhancing medical knowledge. With a multidisciplinary team of experts and state-of-the-art facilities, PUMCH is dedicated to contributing to global health advancements and fostering collaborations in the medical research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported